FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

FILE PHOTO: Picture illustration of a vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine

(Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Leslie Adler)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting